Abstract
Mesenchymal stromal/stem cells (MSCs) have multilineage differentiation potential and as such are known to promote regeneration in response to tissue injury. However, accumulating evidence indicates that the regenerative capacity of MSCs is not via transdifferentiation but mediated by their production of trophic and other factors that promote endogenous regeneration pathways of the tissue cells. In this chapter, we provide a detailed description on how to obtain trophic factors secreted by cultured MSCs and how they can be used in small animal models. More specific, in vivo models to study the paracrine effects of MSCs on regeneration of the liver after surgical resection and/or ischemia and reperfusion injury are described.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Polchert D, Sobinsky J, Douglas G et al (2008) IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Eur J Immunol 38(6): 1745–1755
Sun L, Akiyama K, Zhang H et al (2009) Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 27(6):1421–1432
Fiorina P, Jurewicz M, Augello A et al (2009) Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol 183(2):993–1004
Hawkey CJ (2012) Stem cells as treatment in inflammatory bowel disease. Dig Dis 30(Suppl): 3134–139
Uccelli A, Laroni A, Freedman MS (2011) Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases. Lancet Neurol 10(7):649–656
Lim GB (2012) Stem cells: myocardial regeneration after infarction-promising phase I trial results. Nat Rev Cardiol 9(4):187
Roddy GW, Oh JY, Lee RH et al (2011) Action at a distance: systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-alpha stimulated gene/protein 6. Stem Cells 29(10): 1572–1579
Liu WG, Wang ZY, Huang ZS (2011) Bone marrow-derived mesenchymal stem cells expressing the bFGF transgene promote axon regeneration and functional recovery after spinal cord injury in rats. Neurol Res 33(7): 686–693
Ortiz LA, Dutreil M, Fattman C et al (2007) Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A 104(26):11002–11007
Huang S, Lu G, Wu Y et al (2012) Mesenchymal stem cells delivered in a microsphere-based engineered skin contribute to cutaneous wound healing and sweat gland repair. J Dermatol Sci 66(1):29–36
Karoui M, Penna C, Amin-Hashem M et al (2006) Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243(1):1–7
Kandutsch S, Klinger M, Hacker S et al (2008) Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases. Eur J Surg Oncol 34(11):1231–1236
Skullman S, Ihse I, Larsson J (1990) Influence of malnutrition on regeneration and composition of the liver in rats. Acta Chir Scand 156(10):717–722
Timchenko NA (2009) Aging and liver regeneration. Trends Endocrinol Metab 20(4): 171–176
Shiffman ML, Brown RS Jr, Olthoff KM et al (2002) Living donor liver transplantation: summary of a conference at The National Institutes of Health. Liver Transpl 8(2):174–188
Marsh JW, Gray E, Ness R et al (2009) Complications of right lobe living donor liver transplantation. J Hepatol 51(4):715–724
Dahm F, Georgiev P, Clavien PA (2005) Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant 5(11): 2605–2610
Wu C, Wang P, Rao J et al (2011) Triptolide alleviates hepatic ischemia/reperfusion injury by attenuating oxidative stress and inhibiting NF-kappaB activity in mice. J Surg Res 166(2): e205–213
Selzner N, Rudiger H, Graf R et al (2003) Protective strategies against ischemic injury of the liver. Gastroenterology 125(3):917–936
Cho KA, Ju SY, Cho SJ et al (2009) Mesenchymal stem cells showed the highest potential for the regeneration of injured liver tissue compared with other subpopulations of the bone marrow. Cell Biol Int 33(7): 772–777
Abdel Aziz MT, Atta HM, Mahfouz S et al (2007) Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clin Biochem 40(12): 893–899
Forbes SJ, Vig P, Poulsom R et al (2002) Bone marrow-derived liver stem cells: their therapeutic potential. Gastroenterology 123(2): 654–655
Oertel M, Shafritz DA (2008) Stem cells, cell transplantation and liver repopulation. Biochim Biophys Acta 1782(2):61–74
Duncan AW, Dorrell C, Grompe M (2009) Stem cells and liver regeneration. Gastroenterology 137(2):466–481
Fausto N (2004) Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology 39(6):1477–1487
Kaplan JM, Youd ME, Lodie TA (2010) Immunomodulatory activity of mesenchymal stem cells. Curr Stem Cell Res Ther 6:297–316
Crop M, Baan C, Weimar W et al (2009) Potential of mesenchymal stem cells as immune therapy in solid-organ transplantation. Transpl Int 22(4):365–376
Aguirre A, Planell JA, Engel E (2010) Dynamics of bone marrow-derived endothelial progenitor cell/mesenchymal stem cell interaction in co-culture and its implications in angiogenesis. Biochem Biophys Res Commun 400(2):284–291
Zacharek A, Chen J, Cui X et al (2007) Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke. J Cereb Blood Flow Metab 27(10):1684–1691
da Silva Meirelles L, Chagastelles PC, Nardi NB (2006) Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119(Pt 11):2204–2213
Bieback K, Kern S, Kocaomer A et al (2008) Comparing mesenchymal stromal cells from different human tissues: bone marrow, adipose tissue and umbilical cord blood. Biomed Mater Eng 18(1 Suppl):S71–76
Pan Q, Fouraschen SM, Kaya FS et al (2011) Mobilization of hepatic mesenchymal stem cells from human liver grafts. Liver Transpl 17(5):596–609
Fouraschen SM, Pan Q, de Ruiter PE et al (2012) Secreted factors of human liver-derived mesenchymal stem cells promote liver regeneration early after partial hepatectomy. Stem Cells Dev 21(13):2410–2419
van Poll D, Parekkadan B, Cho CH et al (2008) Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 47(5):1634–1643
Parekkadan B, van Poll D, Suganuma K et al (2007) Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One 2(9):e941
Pan Q, Fouraschen SM, de Ruiter PE et al (2014) Detection of spontaneous tumorigenic transformation during culture expansion of human mesenchymal stromal cells. Exp Biol Med (Maywood) 239(1):105–115 doi: 10.1177/1535370213506802. Epub 2013 Nov 13. PMID: 24227633
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Fouraschen, S.M.G., Hall, S.R.R., de Jonge, J., van der Laan, L.J.W. (2014). Support of Hepatic Regeneration by Trophic Factors from Liver-Derived Mesenchymal Stromal/Stem Cells. In: Christ, B., Oerlecke, J., Stock, P. (eds) Animal Models for Stem Cell Therapy. Methods in Molecular Biology, vol 1213. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1453-1_9
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1453-1_9
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1452-4
Online ISBN: 978-1-4939-1453-1
eBook Packages: Springer Protocols